An emerging hypothesis that stems from these observations is that the loss of quiescent EC-KLF4 is likely pathogenic, therefore normalization of lung microvessel KLF4 levels in patients with chronic lung disease might reverse the course of EndMT and restore the EC quiescence (see graphical abstract, Figure 9). The gene discussed is KLF4; the disease is chronic lung disease.